Abstract
Enhanced oral (po) bioavailability of antimicrobial drugs allows conversion to po therapy once a patient meets defined clinical criteria. This can reduce length of hospital stay, healthcare costs and risk of complications related to intravenous (iv) access. We developed a quality indicator for assessing the appropriate iv-to-po switch of bioavailable antibiotics and evaluated its feasibility and clinical relevance across acute healthcare systems. The study was designed as a multicentre, multinational observational audit. The indicator was the proportion of inappropriate iv treatments at any point in time in adult patients treated with fluoroquinolones, clindamycin, linezolid or metronidazole. Treatments were prospectively evaluated by a trained physician or clinical pharmacist using predefined clinical criteria. The feasibility of the indicator was evaluated by measuring data availability, data collection workload and sensitivity to improvement Data were collected over a 3 month period in five university hospitals in Austria, Belgium and Germany and iv treatment was assessed in 211 patients. The indicator was measurable in 99.1% of cases. By intention-to-treat analysis, 37.0% (95% CI 30.5-43.9) of treatments were inappropriate,...Continue Reading
References
Apr 1, 1997·The Journal of Antimicrobial Chemotherapy·D NathwaniP Davey
Dec 8, 1996·PharmacoEconomics·K M Jensen, J A Paladino
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·F SevinçP Speelman
Mar 27, 2001·Archives of Internal Medicine·J A Ramirez, J Bordon
Jan 31, 2002·Drugs·Friedrich Vogel
Nov 29, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Joseph L KutiRichard Quintiliani
Nov 26, 2003·Archives of Internal Medicine·Michael A FischerJerry Avorn
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensUNKNOWN Infectious Diseases Society of America
Nov 9, 2006·BMJ : British Medical Journal·Jan Jelrik OosterheertAndy I M Hoepelman
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
Dec 5, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nancy Toedter Williams
Citations
Mar 26, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F M BuyleUNKNOWN members of the Antibiotic Strategy International (ABS) Quality Indicators Team
Nov 10, 2013·Medicina intensiva·Dolores EscuderoBrígida Quindós
Dec 12, 2013·Infection·J ThernW V Kern
Jul 23, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D NathwaniC Eckmann
Apr 14, 2016·Infection·K de WithW V Kern
May 1, 2015·BMC Infectious Diseases·Karl Madaras-KellyMatthew Samore
Mar 29, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D NathwaniS Haider
Mar 4, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M BassettiM Wilcox
Apr 29, 2016·The Journal of Antimicrobial Chemotherapy·Jennifer BroomStefanie Plage
Jul 16, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lori A PollackUNKNOWN Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) Expert Panel on Stewardship Structure and Process Indicators
Nov 20, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Benjamin HohlfelderPaul Szumita
Aug 16, 2017·BMC Infectious Diseases·Marvin Ah BerrevoetsBart-Jan Kullberg
Aug 22, 2017·Antimicrobial Resistance and Infection Control·Marvin A H BerrevoetsTom Sprong
Mar 15, 2019·Interdisciplinary Perspectives on Infectious Diseases·Alemseged Beyene Berha, Gizat Molla Kassie
Aug 29, 2019·Emergency Medicine Australasia : EMA·Laura M HamillGerben Keijzers
Mar 19, 2021·BMJ Open Quality·Brendan Joseph McMullanEvette Buono
May 18, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Alaa BabonjiMaha Al-Alwai